Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents-Reference-Cited by-同舟云学术

Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents

Published:2023-01-11 Issue:1 Volume:38 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Khalil Ahmed F.¹^ORCID,El-Moselhy Tarek F.¹,El-Bastawissy Eman A.¹,Abdelhady Rasha²^ORCID,Younis Nancy S.³^ORCID,El-Hamamsy Mervat H.¹

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt

2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Fayoum University, Fayoum, Egypt

3. Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al Hofuf, Saudi Arabia

Funder

Scientific Research, King Faisal University, Saudi Arabia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2022.2157411

Reference60 articles.

1. National cancer institute cancer statistics. 2020. [accessed 10 February 2022]. https://www.Cancer.Gov/about-cancer/understanding/statistics

2. Word health organisation global cancer observatory estimated number of new cases in 2020 worldwide both sexes all ages. 2022. [accessed 17 April 2022]. https://gco.Iarc.Fr/today/online-analysis-table?V=2020&mode=cancer&mode_population=continents&population=900&populations=&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5b%5d=0&ages_group%5b%5d=17&group_cancer=1&include_nmsc=0&include_nmsc_other=1#collapse-by_country

3. National cancer institute cancer stat facts: Leukemia. 2022. [accessed 14 April 2022]. https://seer.Cancer.Gov/statfacts/html/leuks.Html

4. American Cancer Society leukemia in children. 2022. [access 17 April 2022]. https://www.Cancer.Org/cancer/leukemia-in-children.Html

5. Targeting metabolic transformation for cancer therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity;Archiv der Pharmazie;2023-10-12

2. Structure-Based Drug Design of Novel Triaminotriazine Derivatives as Orally Bioavailable IDH2^R140Q Inhibitors with High Selectivity and Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid Leukemia;Journal of Medicinal Chemistry;2023-09-14

3. Experimental Insights into the Interplay between Histone Modifiers and p53 in Regulating Gene Expression;International Journal of Molecular Sciences;2023-07-03

4. Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-04-25

5. Recent biological applications of heterocyclic hybrids containing s-triazine scaffold;RSC Advances;2023